DJ Abbott Laboratories Stock Underperforms Wednesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Abbott Laboratories $(ABT)$ slipped 1.72% to $124.43 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index remaining mostly unchanged at 6,890.59 and the Dow Jones Industrial Average falling 0.16% to 47,632.00.
This was the stock's second consecutive day of losses.
Abbott Laboratories closed 11.90% below its 52-week high of $141.23, which the company achieved on March 4th.
The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson $(JNJ)$ fell 0.18% to $186.60, Pfizer Inc. $(PFE)$ fell 0.86% to $24.29, and Merck & Co. Inc. $(MRK)$ fell 0.52% to $86.58.
Trading volume (5.1 M) remained 623,017 below its 50-day average volume of 5.8 M.
Data source: Dow Jones Market Data, FactSet. Data compiled October 29, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
October 29, 2025 16:33 ET (20:33 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.